Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • vaxherra
    Junior Member
    • Jul 2016
    • 1

    #1

    Metagenomic survey of gut microbiota - depth, tradeoff and num. of samples to include

    Hi there community!

    I am a student currently enrolled in a Research Traineeship Program. My lab studies Systemic Lupus Erythematosus (SLE), and as a part of this research we are investigating microbiome in SLE patients and comparing to control groups.

    So far, we've done 16S rRNA amplicon sequencing of those patients. Some data were generated while I wasn't here (34 fecal samples, 15 controls, 19 SLE patients), and some are fairly recent (75 fecal samples, 25 controls, 50 SLE patients). Still not all samples have been sequenced, some failed PCR, and we'll be soon ordering mock communities in order to enhance our analyses, as some of the outcome results are pipeline-dependent (soft for OTU picking, filtering parameters etc.).

    Since 16S rRNA seems to be inefficient in exploring this immune disease, and "predictive metagenomics" (with PICRUSt software) is far too inaccurate, since the sequences that fail to map to reference (GreenGenes) are thrown out, we've decided to go with Shotgun Sequencing.

    Having read some papers (like: "How much metagenomic sequencing is enough to achieve a given goal?"), it is recommended to use at least 7Gbp (assuming x20 coverage to enumerate gene contents of prokaryotes with relative abundance of more than 1% in the human microbiota). Having 109 samples this is far too expensive. As a first step, I though about sticking to latest dataset, with 75 samples - i.e. reducing the number of samples to sequence. But this is too expensive (75 samples * 7GBp = 525).

    I don't have that much of an experience here, therefore I'd like to ask you, dear community, to help me out here. Direct me to some materials, or provide some suggestions. I don't want to remove patients from my dataset, as statistic power would decrease, but at the same time reducing depth could lead to "shallow" data. What are you thoughts?

    I have "paid" access to Illumina machines listed below:


    Best
    Robert.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...